Cargando…

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of aggressive lymphoma. Approximately 60% of fit patients achieve curation with immunochemotherapy, but the remaining patients relapse or have refractory disease, which predicts a short survival. Traditionally, risk stratification in DLBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosquera Orgueira, Adrián, Díaz Arías, Jose Ángel, Serrano Martín, Rocio, Portela Piñeiro, Victor, Cid López, Miguel, Peleteiro Raíndo, Andrés, Bao Pérez, Laura, González Pérez, Marta Sonia, Pérez Encinas, Manuel Mateo, Fraga Rodríguez, Máximo Francisco, Vallejo Llamas, Juan Carlos, Bello López, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175759/ https://www.ncbi.nlm.nih.gov/pubmed/37188190 http://dx.doi.org/10.3389/fonc.2023.1157646

Ejemplares similares

P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB-CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

PB2384: EVALUATION OF NEW MACHINE LEARNING SYSTEMS FOR PROGNOSTICATION BASED ON GENE EXPRESSION SIGNATURES IN MANTLE CELL AND PERIPHERAL T CELL LYMPHOMAS
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2020)

PB2624: CLINICAL WHOLE EXOM SEQUENCING FOR CONGENITAL PLATELET DISORDERS: ONE SINGLE CENTER EXPERIENCE
por: Piñeiro, Victor Portela, et al.
Publicado: (2023)

Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2023)

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis
por: Gómez-Llobell, Marina, et al.
Publicado: (2022)

Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2020)

A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
por: Tomacinschii, Victor, et al.
Publicado: (2023)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

An Integrative Analysis of Meningioma Tumors Reveals the Determinant Genes and Pathways of Malignant Transformation
por: Iglesias Gómez, José Carlos, et al.
Publicado: (2014)

Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways
por: Mosquera Orgueira, Adrián
Publicado: (2015)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

Deep null fixing on optimal compromise among sum and difference patterns of thinned arrays through the Schelkunoff unit circle representation
por: Raíndo-Vázquez, Mateo, et al.
Publicado: (2022)

Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
por: Perez, Marco, et al.
Publicado: (2016)

Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
por: Ulas, Ezgi B., et al.
Publicado: (2023)

Increased Endothelial Progenitor Cell Levels are Associated with Good Outcome in Intracerebral Hemorrhage
por: Pías-Peleteiro, Juan, et al.
Publicado: (2016)

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
por: Ferrer, Irene, et al.
Publicado: (2018)

An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
por: Rodríguez, Marta, et al.
Publicado: (2022)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

Musculoskeletal Injuries and Risk Factors in Spanish CrossFit(®) Practitioners
por: Lastra-Rodríguez, Lucas, et al.
Publicado: (2023)

Optimizing Radiation Patterns of Thinned Arrays with Deep Nulls Fixed through Their Representation in the Schelkunoff Unit Circle and a Simulated Annealing Algorithm
por: Raíndo-Vázquez, Mateo, et al.
Publicado: (2022)

Contrasted phylogeographic patterns on mitochondrial DNA of shallow and deep brittle stars across the Atlantic-Mediterranean area
por: Taboada, Sergi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i20sl9gp05nc54776np1aoq02p